The Pathophysiology of the Pancreatic Defect in Cystic Fibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1651-2227|78|S363|41-44

ISSN： 0803-5253

Source： ACTA PAEDIATRICA, Vol.78, Iss.S363, 1989-11, pp. : 41-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CFTR, bicarbonate, and the pathophysiology of cystic fibrosis

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. S40, 2015-10 ,pp. : 2S4-S30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 2, 2015-02 ,pp. : 155-166

John Wiley & Sons Inc

Access to resources Recommend Favorite

Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis

By Konstan Michael W   Borowitz Drucy   Mayer-Hamblett Nicole   Milla Carlos   Hendeles Leslie   Murray Susan   Kronmal Richard A   Casey Susan   Rose Lynn M   Morgan Wayne J   Ramsey Bonnie W  

Clinical Investigation, Vol. 3, Iss. 8, 2013-08 ,pp. : 731-741

Future Science

Access to resources Recommend Favorite

Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis

By Konstan Michael W   Accurso Frank J   Nasr Samya Z   Ahrens Richard C   Graff Gavin R  

Clinical Investigation, Vol. 3, Iss. 8, 2013-08 ,pp. : 723-729

Future Science

Access to resources Recommend Favorite

Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 8, 2015-08 ,pp. : 854-865

John Wiley & Sons Inc

Access to resources Recommend Favorite